numer
adjunct
therapeut
agent
investig
treatment
control
fat
mobil
syndrom
periparturi
dairi
cow
aim
studi
determin
effect
multipl
iv
inject
butaphosphan
cyanocobalamin
combin
catos
bayer
anim
health
leverkusen
germani
wk
antepartum
ap
metabol
health
dairi
cow
fortyf
lategest
holsteinfriesian
cow
second
pregnanc
alloc
randomli
group
cowsgroup
group
daili
iv
inject
butaphosphan
mgkg
bodi
weight
bw
cyanocobalamin
bw
last
wk
gestat
group
daili
iv
inject
butaphosphan
mgkg
bw
cyanocobalamin
bw
last
week
gestat
group
equivolum
daili
iv
inject
nacl
solut
serum
biochem
analysi
perform
jugular
venou
blood
sampl
period
obtain
aserum
nonesterifi
fatti
acid
butyr
concentr
number
puerper
infect
first
calv
decreas
group
rel
group
conclud
multipl
inject
catos
closeup
period
benefici
effect
metabol
periparturi
dairi
cow
result
consist
hypothesi
highproduc
dairi
cow
earli
lactat
may
rel
actual
defici
cyanocobalamin
transient
acut
state
neg
energi
balanc
inadequ
dmi
periparturi
period
lead
mobil
larg
amount
bodi
fat
concomit
increas
plasma
nefa
concentr
accumul
lipid
liver
dairi
cow
grummer
enhanc
lipolysi
periparturi
period
first
identifi
term
fat
mobil
syndrom
morrow
morrow
increas
lipolysi
periparturi
dairi
cow
accompani
increas
incid
clinic
import
diseas
ketosi
retain
placenta
metriti
mastiti
abomas
displac
reduc
immun
resist
morrow
curti
et
al
gerloff
et
al
fat
mobil
syndrom
character
periparturi
increas
serum
nefa
bhba
concentr
decreas
serum
glucos
insulin
concentr
aeberhard
et
al
syndrom
associ
decreas
product
reproduct
perform
butler
leroy
et
al
increas
morbid
death
sever
affect
anim
treatment
prevent
fat
mobil
syndrom
focus
maxim
energi
dmi
periparturi
period
numer
adjunct
therapeut
agent
decreas
periparturi
lipolysi
promot
fatti
acid
oxid
hepat
mitochondria
facilit
export
lipoprotein
liver
investig
adjunct
agent
treatment
control
fat
mobil
syndrom
studi
periparturi
dairi
cow
evalu
effect
oral
administ
propylen
glycol
propion
kristensen
raun
grummer
glycerol
defrain
et
al
nicotin
acid
drackley
et
al
pire
et
al
cislinol
acid
selberg
et
al
mosley
et
al
fat
drackley
et
al
moallem
et
al
methionin
preynat
et
al
cholin
chung
et
al
carnitin
lacount
et
al
carlson
et
al
monensin
ari
et
al
duffield
et
al
fat
mobil
syndrom
potenti
adjunct
treatment
insulin
glucagon
dexamethason
evalu
suffer
sever
associ
problem
affect
current
use
nafikov
et
al
continu
need
adjunct
therapeut
agent
effect
treatment
prevent
fat
mobil
syndrom
periparturi
dairi
cow
catos
bayer
anim
health
leverkusen
germani
commerci
avail
mixtur
cyanocobalamin
cyanocobalaminml
phosphoruscontain
compound
mg
butaphosphanml
label
improv
energi
metabol
cattl
pig
countri
sourc
cyanocobalamin
phosphoru
prevent
treatment
defici
nutrient
cattl
swine
hors
poultri
unit
state
label
dose
catos
unit
state
lb
bw
iv
im
sc
inject
equival
butaphosphan
mgkg
bw
cyanocobalamin
bw
inject
repeat
daili
increas
milk
milk
protein
yield
observ
follow
intramuscular
cyanocobalamin
administr
mgcow
per
week
oral
cyanocobalamin
supplement
mgcow
per
day
girard
matt
graulet
et
al
effect
metabol
variabl
schuh
et
al
lohr
et
al
dairi
cattl
phosphoru
content
liver
tissu
decreas
earli
lactat
due
reduct
hepatocellular
cytosol
volum
well
decreas
cytosol
phosphoru
concentr
et
al
phosphoru
supplement
may
therefor
indic
periparturi
dairi
cow
phosphoru
play
import
role
hepat
carbohydr
metabol
intermedi
gluconeogen
pathway
must
phosphoryl
rate
gluconeogenesi
glycolysi
regul
phosphoru
avail
berg
et
al
sever
report
indic
reduct
morbid
follow
administr
butaphosphan
cyanocobalamin
sommer
et
al
flasshoff
palmer
schuh
recent
report
indic
inject
butaphosphan
cyanocobalamin
day
calv
later
decreas
preval
subclin
ketosi
week
calv
matur
dairi
cow
rollin
et
al
therefor
hypothes
parenter
administr
catos
late
dri
period
would
improv
energi
metabol
periparturi
dairi
cattl
accordingli
main
aim
studi
determin
effect
multipl
iv
inject
cyanocobalamin
butaphosphan
combin
catos
administ
wk
antepartum
ap
metabol
dairi
cow
studi
conduct
holsteinfriesian
herd
standard
hous
environment
condit
herd
dairi
cow
milk
yield
lcow
cow
kept
loos
hous
slat
floor
separ
pen
similar
milk
yield
dri
period
close
lactat
follow
day
cow
milk
twice
daili
use
sidebysid
system
xpressway
suprem
boumat
gascoign
melott
remicourt
belgium
cow
identif
system
cow
trakker
boumat
gascoign
melott
automat
record
milk
volum
perfect
boumat
gascoign
melott
fortyf
cow
late
gestat
second
pregnanc
admit
studi
random
basi
schulz
grime
cow
dri
wk
ap
clinic
healthi
feed
routin
composit
standard
tabl
cow
administ
standard
immun
program
late
gestat
protect
calv
escherichia
coli
salmonella
typhimurium
rotaviru
coronaviru
infect
clinic
ill
cow
exclud
studi
cow
randomli
assign
group
use
random
number
gener
data
analysi
tool
microsoft
offic
excel
wwwmicrosoftcom
treatment
sampl
plan
shown
figur
first
group
n
receiv
total
catos
butaphosphan
cyanocobalamin
combin
bayer
anim
health
iv
inject
kg
bw
administ
sequenti
iv
inject
everi
h
ap
ap
figur
second
group
n
receiv
sequenti
nacl
kg
bw
iv
inject
everi
h
ap
sequenti
catos
iv
inject
everi
h
ap
third
group
n
administ
iv
inject
nacl
kg
bw
everi
h
ap
journal
dairi
scienc
vol
et
al
ap
daili
dosag
catos
cow
group
butaphosphan
mgkg
bw
cyanocobalamin
bw
approxim
time
higher
upper
rang
label
dose
daili
administr
butaphosphan
mgkg
bw
cyanocobalamin
bw
cattl
unit
state
blood
collect
extern
jugular
vein
plain
glass
vacutain
tube
morn
immedi
first
second
treatment
catos
placebo
pp
pp
time
point
select
span
time
interv
greatest
metabol
stress
parturit
morrow
gerloff
et
al
provid
total
time
point
serum
biochem
analysi
cow
monitor
clinic
lactat
pp
rectal
temperatur
measur
twice
daili
first
pp
presenc
puerper
infect
defin
rectal
bodi
temperatur
milk
volum
record
daili
first
month
pp
milk
composit
fat
protein
lactos
determin
one
time
first
month
pp
part
govern
milk
yield
monitor
program
milk
fat
protein
lactos
concentr
measur
use
infrar
spectroscopi
milkoscan
ft
foss
analyt
denmark
milk
scc
measur
use
optic
fluoresc
method
fossomat
fc
foss
analyt
jugular
venou
blood
allow
clot
room
temperatur
centrifug
g
serum
harvest
store
serum
thaw
room
temperatur
immedi
analysi
follow
metabol
paramet
determin
use
automat
analyz
hitachi
autom
chemistri
analyz
boehring
mannheim
mannheim
germani
nefa
colorimetr
method
base
reaction
atp
coenzym
nefa
bhba
measur
follow
convers
acetoacet
turn
convert
nad
nadh
glucos
glucos
hexokinas
total
bilirubin
diazot
sulfanil
acid
cholesterol
colorimetr
concentr
well
serum
activ
aspart
aminotransferas
ast
aspart
tri
buffer
method
alkalin
phosphatas
alp
pnitrophenol
method
creatin
kinas
ck
nacetyllcysteineactiv
uv
method
follow
serum
concentr
also
determin
cyanocobalamin
electrochemiluminesc
immunoassay
rochehitachi
modular
basel
switzerland
insulin
insimmunoradiometr
ria
biosourc
europ
sa
hamburg
germani
cortisol
ria
abraham
et
al
cobalt
selenium
flow
inject
analysi
systemtransvers
heat
graphit
atom
coupl
graphit
tubeaa
perkin
elmer
germani
data
express
mean
standard
deviat
geometr
mean
ci
p
consid
signific
repeatedmeasur
anova
use
proc
mix
sa
sa
institut
inc
cari
nc
autoregress
covari
structur
use
determin
main
effect
group
level
time
level
interact
group
time
valu
serum
cyanocobalamin
phosphoru
glucos
nefa
total
bilirubin
cortisol
insulin
concentr
serum
ck
ast
activ
logtransform
achiev
homogen
varianc
meet
one
assumpt
anova
bonferroniadjust
pvalu
use
assess
differ
tween
group
time
point
whenev
ftest
group
group
time
interact
signific
bonferroniadjust
pvalu
use
assess
chang
time
day
valu
group
whenev
ftest
time
group
time
interact
signific
fisher
exact
test
proc
freq
sa
sa
institut
use
compar
number
cow
group
puerper
infect
analysi
varianc
use
proc
glm
sa
sa
institut
dim
sampl
covari
use
determin
main
effect
group
level
milk
product
log
scc
fat
percentag
protein
percentag
lactos
concentr
first
herd
test
parturit
signific
group
effect
present
serum
cyanocobalamin
p
total
bilirubin
p
glucos
p
bhba
p
concentr
expect
periparturi
dairi
cattl
signific
time
effect
serum
biochem
variabl
measur
signific
group
time
interact
present
serum
cyanocobalamin
p
total
bilirubin
p
nefa
p
glucos
p
concentr
serum
concentr
cyanocobalamin
increas
group
compar
cow
untreat
group
figur
differ
serum
cobalt
concentr
group
ap
pp
data
shown
serum
phosphoru
concentr
decreas
pp
pp
group
group
serum
glucos
concentr
higher
group
group
pp
figur
serum
nefa
concentr
increas
calv
group
lower
group
pp
group
serum
bhba
concentr
increas
calv
group
group
lower
group
pp
group
serum
cortisol
concentr
increas
calv
differ
group
figur
serum
insulin
concentr
decreas
calv
group
serum
total
bilirubin
concentr
increas
calv
group
howev
serum
total
bilirubin
concentr
lower
group
pp
group
figur
serum
calcium
concentr
decreas
group
pp
differ
group
signific
differ
serum
cholesterol
magnesium
selenium
concentr
serum
ast
alp
ck
activ
group
observ
time
point
data
shown
puerper
infect
first
present
cow
group
p
compar
control
group
cow
group
p
compar
control
group
cow
control
group
cow
group
therefor
receiv
fewest
intrauterin
inject
antimicrobi
treatment
differ
daili
cumul
milk
yield
group
figur
cow
group
highest
lactos
concentr
first
milk
test
calv
adjust
day
milk
tabl
major
find
studi
report
multipl
iv
inject
cyanocobalamin
butaphosphan
parturit
increas
glucos
avail
evalu
pp
serum
glucos
concentr
decreas
peripher
fat
mobil
keton
bodi
format
evalu
pp
serum
nefa
bhba
concentr
time
greatest
metabol
stress
morrow
gerloff
et
al
decreas
number
puerper
infect
improv
pp
metabol
statu
tempor
associ
increas
serum
cyanocobalamin
concentr
ap
although
associ
prove
causal
relationship
causal
relationship
like
event
chronolog
link
dosedepend
relationship
identifi
biolog
plausibl
mechan
relationship
result
consist
hypothesi
highproduc
dairi
cow
earli
lactat
may
rel
actual
defici
cyanocobalamin
suggest
cyanocobalamin
defici
may
contribut
develop
fat
mobil
syndrom
serum
cyanocobalamin
concentr
low
earli
lactat
cyanocobalamin
suppli
consid
limit
factor
lactat
perform
methylmalonylcoa
mutas
cyanocobalamindepend
enzym
transform
methylmalonylcoa
succinylcoa
cyanocobalamin
therefor
play
pivot
role
entri
propion
kreb
cycl
util
propion
gluconeogenesi
korpela
girard
matt
observ
directli
lead
hypothesi
cyanocobalamin
defici
contribut
fat
mobil
syndrom
decreas
rate
propion
util
gluconeogenesi
cyanocobalamin
requir
dairi
cattl
mgd
steinberg
daili
requir
provid
metabol
activ
rumin
bacteria
produc
mean
mg
cyanocobalamin
per
day
lactat
holsteinfriesian
cow
howev
oral
bioavail
cyanocobalamin
low
santschi
et
al
comparison
cow
group
studi
report
receiv
mg
cyanocobalamin
iv
daili
ap
respect
increas
serum
cyanocobalamin
concentr
dosedepend
manner
dose
cyanocobalamin
administ
cow
studi
report
biolog
relev
cyanocobalamin
essenti
gluconeogenesi
propion
korpela
girard
matt
rel
defici
cyanocobalamin
would
expect
decreas
glucos
avail
affect
bioenerget
lactos
synthesi
propion
major
gluconeogen
substrat
highyield
dairi
cow
preynat
et
al
higher
serum
glucos
insulin
concentr
lower
serum
nefa
bhba
concentr
higher
milk
lactos
concentr
group
cow
calv
studi
consist
increas
glucos
avail
increas
dmi
although
neither
factor
directli
measur
studi
report
result
studi
lactat
dairi
cow
indic
cyanocobalamin
administr
increas
glucos
availjourn
dairi
scienc
vol
et
al
figur
effect
multipl
iv
inject
cyanocobalamin
butaphosphan
administ
wk
antepartum
ap
serum
glucos
nefa
bhba
concentr
dairi
cow
fortyf
lategest
holsteinfriesian
cow
alloc
randomli
group
cowsgroup
group
iv
inject
cyanocobalamin
butaphosphan
last
wk
gestat
group
iv
inject
cyanocobalamin
butaphosphan
last
week
gestat
group
equivolum
iv
inject
nacl
solut
data
mean
sd
p
bonferroni
adjust
group
time
bonferroni
adjust
time
valu
abil
lactat
perform
absenc
increas
dmi
preynat
et
al
result
compar
previou
studi
dairi
cow
util
formul
cyanocobalamin
butaphosphan
sommer
et
al
flasshoff
palmer
schuh
et
al
lohr
et
al
rollin
et
al
previou
studi
administ
sc
iv
dose
cyanocobalamin
mgcow
butaphosphan
gcow
occas
approxim
iv
dose
cyanocobalamin
mgcow
butaphosphan
g
cow
administ
group
group
occas
cow
studi
report
result
previous
publish
studi
comparison
effect
differ
dosag
protocol
use
studi
report
indic
effect
cyanocobalamin
butaphosphan
combin
dosedepend
bioenerget
favor
respons
may
requir
least
iv
inject
least
mg
cyanocobalamin
g
butaphosphan
cow
note
dri
period
cow
studi
report
unknown
whether
treatment
cow
longer
dri
period
typic
dairi
would
led
differ
result
butaphosphan
phosphon
acid
deriv
contain
phosphoru
precis
mode
action
butaphosphan
metabol
unknown
direct
effect
butaphosphan
phosphoru
homeostasi
anim
remain
unknown
emea
question
whether
effect
butaphosphan
simpli
matter
substitut
phosphoru
emea
butaphosphan
inject
cow
studi
report
immedi
result
increas
serum
phosphoru
concentr
figur
howev
serum
phosphoru
calcium
concentr
numer
higher
group
cow
pp
group
cow
figur
figur
result
like
reflect
numer
higher
milk
product
first
day
parturit
group
cow
lactat
major
drain
calcium
phosphoru
numer
higher
serum
calcium
phosphoru
concentr
group
cow
pp
may
also
reflect
improv
overal
health
rather
direct
effect
butaphosphan
serum
phosphoru
concentr
serum
phosphoru
concentr
decreas
earli
lactat
dairi
cow
decreas
feed
intak
gastrointestin
motil
gruenberg
et
al
serum
calcium
phosphoru
concentr
first
week
calv
affect
sc
administr
ml
catos
day
calv
later
rollin
et
al
support
concept
element
phosphoru
butaphosphan
directli
increas
serum
phosphoru
concentr
dairi
cattl
major
label
indic
butaphosphan
treat
disord
metabol
support
treatment
infertil
tetani
paresi
adjunct
calcium
magnesium
therapi
emea
emea
butaphosphan
rapidli
elimin
primarili
via
urinari
tract
iv
administr
termin
halflif
min
lactat
dairi
cow
emea
although
butaphosphan
administr
alter
basal
serum
insulin
cortisol
concentr
studi
report
figur
butaphosphan
shown
facilit
insulin
releas
glucos
entri
insulindepend
cell
decreas
cortisol
releas
nonlact
dairi
heifer
hansel
et
al
piglet
undergo
social
stress
van
der
staay
et
al
unidentifi
mechan
butaphosphan
may
contribut
benefici
effect
catos
administr
cow
group
addit
investig
necessari
clarifi
possibl
synergist
action
butaphosphan
cyanocobalamin
energi
metabol
believ
help
compar
effect
adjunct
treatment
periparturi
stabil
metabol
oral
propylen
glycol
propion
glycerol
nicotin
acid
cislinol
acid
fat
methionin
cholin
carnitin
monensin
decreas
nefa
concentr
pp
achiev
studi
group
daili
dose
propylen
glycol
exceed
ml
equival
dri
propylen
glycol
formul
fed
requir
significantli
chang
serum
nefa
glucos
insulin
concentr
periparturi
dairi
cattl
kristensen
raun
grummer
dose
magnitud
current
approv
within
european
union
protect
effect
glycerol
supplement
transit
cow
feed
variabl
defrain
et
al
consensu
propylen
glycol
provid
superior
predict
metabol
respons
glycerol
periparturi
dairi
cow
metabol
effect
nicotin
acid
dosedepend
drackley
et
al
pire
et
al
although
cislinol
acid
supplement
decreas
milk
fat
content
selberg
et
al
mosley
et
al
metabol
effect
treatment
unclear
ad
fat
rumin
ration
effect
stabil
energi
metabol
although
decreas
dmi
increas
serum
nefa
bhba
concentr
describ
moallem
et
al
neither
rumenprotect
methionin
preynat
et
al
cholin
chung
et
al
plasma
nefa
bhba
concentr
lactat
dairi
cow
although
rumenprotect
methionin
decreas
milk
lactos
concentr
increas
milk
protein
concentr
preynat
et
al
carnitin
supplement
monensin
administr
result
mark
decreas
serum
nefa
bhba
concentr
periparturi
cow
lacount
et
al
carlson
et
al
ari
et
al
duffield
et
al
dexamethason
use
great
effect
postpartum
stabil
metabol
decreas
serum
nefa
bilirubin
concentr
use
ap
effect
induc
parturit
increas
incid
retain
placenta
summari
multipl
iv
inject
cyanocobalamin
butaphosphan
commerci
avail
formul
catos
closeup
period
benefici
effect
metabol
periparturi
dairi
cow
result
consist
hypothesi
highproduc
dairi
cow
earli
lactat
may
rel
actual
defici
cyanocobalamin
addit
studi
indic
investig
potenti
synergist
effect
cyanocobalamin
butaphosphan
improv
metabol
statu
health
dairi
cow
earli
lactat
whether
cyanocobalamin
butaphosphan
increas
dmi
periparturi
dairi
cow
whether
benefici
effect
catos
present
multipl
inject
administ
ap
label
dose
cattl
unit
state
